11/7
08:36 am
qncx
Quince Therapeutics, Inc. (NASDAQ: QNCX) is now covered by analysts at Maxim Group. They set a "buy" rating and a $6.00 price target on the stock.
Medium
Report
Quince Therapeutics, Inc. (NASDAQ: QNCX) is now covered by analysts at Maxim Group. They set a "buy" rating and a $6.00 price target on the stock.
11/7
08:27 am
qncx
Rating for QNCX
Medium
Report
Rating for QNCX
11/7
07:42 am
qncx
Quince Therapeutics initiated with bullish view at Maxim
Medium
Report
Quince Therapeutics initiated with bullish view at Maxim
10/29
08:00 am
qncx
Quince Therapeutics, Inc. (NASDAQ: QNCX) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $11.00 price target on the stock.
Medium
Report
Quince Therapeutics, Inc. (NASDAQ: QNCX) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $11.00 price target on the stock.
10/29
08:00 am
qncx
Quince Therapeutics, Inc. (NASDAQ: QNCX) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $11.00 price target on the stock.
Medium
Report
Quince Therapeutics, Inc. (NASDAQ: QNCX) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $11.00 price target on the stock.
10/29
07:33 am
qncx
Rating for QNCX
High
Report
Rating for QNCX
10/29
06:57 am
qncx
Quince Therapeutics initiated with bullish view at Rodman & Renshaw
High
Report
Quince Therapeutics initiated with bullish view at Rodman & Renshaw
10/29
06:57 am
qncx
Quince Therapeutics initiated with bullish view at Rodman & Renshaw
High
Report
Quince Therapeutics initiated with bullish view at Rodman & Renshaw